The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 185K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaisho, T.
Right arrow Articles by Akira, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaisho, T.
Right arrow Articles by Akira, S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1999/12/1573/ $5.00
The Journal of Experimental Medicine, Volume 190, Number 11, December 6, 1999 1573-1582

Original Article

Impairment of Natural Killer Cytotoxic Activity and Interferon {gamma} Production in Ccaat/Enhancer Binding Protein {gamma}–Deficient Mice

Tsuneyasu Kaishoa,d, Hiroko Tsutsuib,d, Takashi Tanakae, Tohru Tsujimurac, Kiyoshi Takedad,f, Taro Kawaid,f, Nobuaki Yoshidag, Kenji Nakanishia,b,d, and Shizuo Akirad,f

a Institute for Advanced Medical Sciences, Hyogo College of Medicine, Hyogo 663-8501, Japan
b Department of Immunology and Medical Zoology, Hyogo College of Medicine, Hyogo 663-8501, Japan
c Department of Pathology, Hyogo College of Medicine, Hyogo 663-8501, Japan
d Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Tokyo 101-0062, Japan
e Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115
f Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
g Division of Gene Expression and Regulation, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
Dept. of Host Defense, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.81-6-6879-830581-6-6879-8302

sakira{at}biken.osaka-u.ac.jp

We have investigated in vivo roles of CCAAT/enhancer binding protein {gamma} (C/EBP{gamma}) by gene targeting. C/EBP{gamma}-deficient (C/EBP{gamma}2/–) mice showed a high mortality rate within 48 h after birth. To analyze the roles of C/EBP{gamma} in lymphoid lineage cells, bone marrow chimeras were established. C/EBP{gamma}2/– chimeras showed normal T and B cell development. However, cytolytic functions of their splenic natural killer (NK) cells after stimulation with cytokines such as interleukin (IL)-12, IL-18, and IL-2 were significantly reduced as compared with those of control chimera NK cells. In addition, the ability of C/EBP{gamma}–/– chimera splenocytes to produce interferon (IFN)-{gamma} in response to IL-12 and/or IL-18 was markedly impaired. NK cells could be generated in vitro with normal surface marker expression in the presence of IL-15 from C/EBP{gamma}2/– newborn spleen cells. However, they also showed lower cytotoxic activity and IFN-{gamma} production when stimulated with IL-12 plus IL-18 than control NK cells, as observed in C/EBP{gamma}2/– chimera splenocytes. In conclusion, our study reveals that C/EBP{gamma} is a critical transcription factor involved in the functional maturation of NK cells.

Key Words: gene targeting • natural killer cells • C/EBP{gamma} • interleukin 15 • interferon {gamma}

T. Kaisho's current address is Dept. of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Abbreviations used in this paper: AP, activator protein; C/EBPs, CCAAT/enhancer binding proteins; IRF, IFN regulatory factor; LT, lymphotoxin; NF, nuclear factor; RAG, recombination activating gene; RT, reverse transcriptase; STAT, signal transducer and activator of transcription.

© 1999 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS